phloroglucinol has been researched along with Breast Cancer in 9 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties." | 7.83 | Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016) |
| "Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect." | 5.42 | Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015) |
| "Poor prognosis of breast cancer patients is closely associated with metastasis and relapse." | 5.42 | Novel anticancer activity of phloroglucinol against breast cancer stem-like cells. ( Hyun, JW; Kim, C; Kim, RK; Lee, SJ; Suh, Y; Uddin, N, 2015) |
| "The microbial polyketide, 2, 4-diacetylphloroglucinol (DAPG), exhibited a broad-spectrum of anti-leukemic, anti-lung, and anti-breast cancer properties." | 3.83 | Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins. ( Kennedy, K; Krishna, R; Lakshmi, P; Sakthivel, N; Veena, VK, 2016) |
| " cava)-derived dieckol on movement behavior and the expression of migration-related genes in MCF-7 human breast cancer cell." | 3.81 | First evidence that Ecklonia cava-derived dieckol attenuates MCF-7 human breast carcinoma cell migration. ( Choi, EJ; Hwang, JW; Jeon, YJ; Kim, EK; Kim, YS; Lee, JH; Lee, SH; Park, PJ; Tang, Y, 2015) |
| "Treatment with phloroglucinol effectively inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG without causing a cytotoxic effect." | 1.42 | Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition. ( Cui, YH; Hwang, E; Kang, JS; Kim, HJ; Kim, MJ; Kim, RK; Lee, SJ; Lee, YY; Suh, Y; Yoo, KC, 2015) |
| "Poor prognosis of breast cancer patients is closely associated with metastasis and relapse." | 1.42 | Novel anticancer activity of phloroglucinol against breast cancer stem-like cells. ( Hyun, JW; Kim, C; Kim, RK; Lee, SJ; Suh, Y; Uddin, N, 2015) |
| "To uncover genetic dependencies in breast cancer cells that harbor active beta-catenin signaling, we performed RNAi-based loss-of-function screens in breast cancer cell lines in which we had characterized beta-catenin activity." | 1.36 | CK1epsilon is required for breast cancers dependent on beta-catenin activity. ( Boehm, JS; Dunn, IF; Firestein, R; Gupta, P; Hahn, WC; Kim, SY; Lander, ES; Ramaswamy, S; Repich, K; Root, DE; Schinzel, AC; Silver, SJ; Wardwell, L; Wittner, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, L | 1 |
| Liu, Y | 1 |
| Li, L | 1 |
| Qin, FL | 1 |
| Li, CJ | 1 |
| Zhou, YQ | 1 |
| Zhou, YN | 1 |
| Wang, H | 1 |
| Jiao, Y | 1 |
| Zhao, L | 1 |
| Kim, RK | 2 |
| Suh, Y | 2 |
| Yoo, KC | 1 |
| Cui, YH | 1 |
| Hwang, E | 1 |
| Kim, HJ | 1 |
| Kang, JS | 1 |
| Kim, MJ | 1 |
| Lee, YY | 1 |
| Lee, SJ | 2 |
| Kim, EK | 1 |
| Tang, Y | 1 |
| Kim, YS | 1 |
| Hwang, JW | 1 |
| Choi, EJ | 1 |
| Lee, JH | 1 |
| Lee, SH | 1 |
| Jeon, YJ | 1 |
| Park, PJ | 1 |
| Uddin, N | 1 |
| Hyun, JW | 1 |
| Kim, C | 1 |
| Veena, VK | 1 |
| Kennedy, K | 1 |
| Lakshmi, P | 1 |
| Krishna, R | 1 |
| Sakthivel, N | 1 |
| Kong, CS | 1 |
| Kim, JA | 1 |
| Yoon, NY | 1 |
| Kim, SK | 1 |
| Kim, SY | 1 |
| Dunn, IF | 1 |
| Firestein, R | 1 |
| Gupta, P | 1 |
| Wardwell, L | 1 |
| Repich, K | 1 |
| Schinzel, AC | 1 |
| Wittner, B | 1 |
| Silver, SJ | 1 |
| Root, DE | 1 |
| Boehm, JS | 1 |
| Ramaswamy, S | 1 |
| Lander, ES | 1 |
| Hahn, WC | 1 |
| Zhang, Y | 1 |
| Luo, M | 1 |
| Zu, Y | 1 |
| Fu, Y | 1 |
| Gu, C | 1 |
| Wang, W | 1 |
| Yao, L | 1 |
| Efferth, T | 1 |
| Garzia, L | 1 |
| D'Angelo, A | 1 |
| Amoresano, A | 1 |
| Knauer, SK | 1 |
| Cirulli, C | 1 |
| Campanella, C | 1 |
| Stauber, RH | 1 |
| Steegborn, C | 1 |
| Iolascon, A | 1 |
| Zollo, M | 1 |
9 other studies available for phloroglucinol and Breast Cancer
| Article | Year |
|---|---|
Pharmacokinetics and tissue distribution of Ebracteolatain A, a potential anti-cancer compound, as determined by an optimized ultra-performance liquid chromatography tandem mass spectrometry method.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Chr | 2019 |
Phloroglucinol suppresses metastatic ability of breast cancer cells by inhibition of epithelial-mesenchymal cell transition.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Epithelial-Mesenchymal Transition; | 2015 |
First evidence that Ecklonia cava-derived dieckol attenuates MCF-7 human breast carcinoma cell migration.
Topics: Antineoplastic Agents; Benzofurans; Breast Neoplasms; Cell Movement; Cell Survival; Dioxanes; Dioxin | 2015 |
Novel anticancer activity of phloroglucinol against breast cancer stem-like cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Death; Female; Humans; MCF-7 Cells; Mice; Mic | 2015 |
Anti-leukemic, anti-lung, and anti-breast cancer potential of the microbial polyketide 2, 4-diacetylphloroglucinol (DAPG) and its interaction with the metastatic proteins than the antiapoptotic Bcl-2 proteins.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Humans; Leukemia; Lung Neoplasms; Molecul | 2016 |
Induction of apoptosis by phloroglucinol derivative from Ecklonia Cava in MCF-7 human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Brea | 2009 |
CK1epsilon is required for breast cancers dependent on beta-catenin activity.
Topics: Animals; beta Catenin; Breast Neoplasms; Casein Kinase 1 epsilon; Cell Line; Cell Line, Tumor; Cell | 2010 |
Dryofragin, a phloroglucinol derivative, induces apoptosis in human breast cancer MCF-7 cells through ROS-mediated mitochondrial pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Dryopteris | 2012 |
Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility.
Topics: Animals; Binding, Competitive; Breast Neoplasms; Caenorhabditis elegans; Carrier Proteins; Cell Comm | 2008 |